Stroke Care 1 Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke

被引:135
作者
Rothwell, Peter M. [1 ]
Algra, Ale [2 ,3 ]
Amarenco, Pierre [4 ,5 ]
机构
[1] Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford, England
[2] Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht Stroke Ctr, NL-3508 TA Utrecht, Netherlands
[3] Univ Med Ctr, Julius Ctr Gen Hlth Sci & Primary Care, Utrecht, Netherlands
[4] Univ Paris 07, INSERM, Grp Hosp Bichat Claude Bernard, Dept Neurol,Rech Clin Atherothrombose,U 698, Paris, France
[5] Univ Paris 07, INSERM, Grp Hosp Bichat Claude Bernard, Stroke Dept,Rech Clin Atherothrombose,U 698, Paris, France
关键词
DENSITY-LIPOPROTEIN-CHOLESTEROL; SYMPTOMATIC CAROTID STENOSIS; PLASMA TRIGLYCERIDE LEVELS; BLOOD-PRESSURE REDUCTION; AGGRESSIVE REDUCTION; CARDIOVASCULAR EVENTS; VASCULAR EVENTS; EARLY RISK; RECURRENT STROKE; MINOR STROKE;
D O I
10.1016/S0140-6736(11)60516-3
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Stroke is a major cause of death and disability worldwide. Without improvements in prevention, the burden will increase during the next 20 years because of the ageing population, especially in developing countries. Major advances have occurred in secondary prevention during the past three decades, which demonstrate the broader potential to prevent stroke. We review the main medical treatments that should be considered for most patients with transient ischaemic attack or ischaemic stroke in the acute phase and the long term, and draw attention to recent developments.
引用
收藏
页码:1681 / 1692
页数:12
相关论文
共 133 条
[1]
Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
[2]
Albers GW, 2003, LANCET, V362, P1691
[3]
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia [J].
Algra, A ;
vanGijn, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) :197-199
[4]
Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin [J].
Algra, A ;
Van Gijn, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02) :255-255
[5]
Digestion of the Antiplatelets Comparison of PRoFESS 18-7=1? [J].
Algra, Ale .
STROKE, 2009, 40 (05) :1932-1935
[6]
*AM HEART ASS, SS10 LAT BREAK CLIN
[7]
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review [J].
Amarenco, Pierre ;
Labreuche, Julien ;
Touboul, Pierre-Jean .
ATHEROSCLEROSIS, 2008, 196 (02) :489-496
[8]
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack - The stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Szarek, Michael ;
Sillesen, Henrik ;
Rudolph, Amy E. ;
Callahan, Alfred, III ;
Hennerici, Michael ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. Michael A. .
STROKE, 2007, 38 (12) :3198-3204
[9]
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention [J].
Amarenco, Pierre ;
Labreuche, Julien .
LANCET NEUROLOGY, 2009, 8 (05) :453-463
[10]
Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Messig, Michael ;
O'Neill, Blair J. ;
Callahan, Alfred, III ;
Sillesen, Henrik ;
Hennerici, Michael G. ;
Zivin, Justin A. ;
Welch, K. M. A. .
STROKE, 2009, 40 (07) :2486-2492